Dermatitis Newswire

Dermatitis Newswire

Comprehensive Real-Time News Feed for Dermatitis.

Results 1 - 20 of 23 in Dermatitis

  1. PHat 5.5 Soap-Free Seborrheic Dermatitis Wash Reduces Skin InflammationRead the original story

    Tuesday Jun 28 | Emailwire.com

    Clearwater, Florida -- Seborrheic dermatitis is a form of eczema that affects the face and scalp. This skin aliment can impact both adults and infants and can sometimes be associated with other skin problems like psoriasis and scalp dandruff.

    Comment?

  2. Global Atopic Dermatitis 2016 Edition: Key Major Players Are Sanofi, GSK, AstraZeneca & Roche HoldingRead the original story w/Photo

    Jun 21, 2016 | SBWire

    Atopic dermatitis is a chronic, inflammatory skin disease of unknown origin that usually starts in early infancy, but also affects a substantial number of adults. Atopic dermatitis is a long lasting skin disease that affects a large percentage of the world's population and is a special type of hypersensitivity that is associated with asthma, inhalant allergies , and a chronic dermatitis.

    Comment?

  3. Global Atopic Dermatitis Market Report: 2016 Edition - New Report by Koncept AnalyticsRead the original story w/Photo

    Jun 21, 2016 | PR Log

    DELHI, India - June 21, 2016 - PRLog -- Atopic dermatitis is a chronic, inflammatory skin disease of unknown origin that usually starts in early infancy, but also affects a substantial number of adults. Atopic dermatitis is a type of chronic eczematous skin disease.

    Comment?

  4. Regeneron and Sanofi's Dermatitis Drug Meets Goals in Late-Stage StudyRead the original story

    Jun 5, 2016 | BioSpace

    Regeneron and Sanofi Announce that Dupilumab Used with Topical Corticosteroids was Superior to Treatment with TCS Alone in Long-term Phase 3 Trial in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients - Moderate-to-severe atopic dermatitis is a serious, chronic inflammatory skin disease marked by widespread rash, itching and associated psychosocial comorbidities These data, along with previous Phase 3 studies, will be part of a U.S. regulatory submission for dupilumab, which is on track for Q3 of 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. and Sanofi today announced that a one-year Phase 3 study, known as LIBERTY AD CHRONOS, evaluating investigational dupilumab met its primary and key secondary endpoints.

    Comment?

  5. Pfizer to splash USD5.2bn cash on eczma group AnacorRead the original story w/Photo

    May 16, 2016 | Live Charts

    Pfizer has agreed to acquire Nasdaq-listed Anacor for $5.2bn cash ahead of potential regulatory approval for its crisaborole dermatitis treatment. Pfizer, which is funding the $99.25-per-share deal through existing cash resources, said it expects the addition of Anacor would enhance near-term revenue growth and would be a strong fit with its Inflammation and Immunology arm.

    Comment?

  6. All you need to know about glutenRead the original story w/Photo

    May 11, 2016 | The Daily Star

    ... but only about 1-3% of people actually do. Celiac disease can also cause gluten-related skin problems, such as dermatitis herpetiformis. Symptoms of dermatitis herpetiformis include an itchy, red rash with raised blisters. Gluten is not necessarily ...

    Comment?

  7. 'Second skin' banishes signs of ageing for 24 hoursRead the original story w/Photo

    May 9, 2016 | Sunday Herald

    ... expect the silicon-based "biomimetic film" will initially be used for medical purposes, such as treating dermatitis and other skin conditions. As well as appealing to the vain, the "skin" could in future be used to dress wounds, screen out harmful ...

    Comment?

  8. Sanofi's Quarter Shows Why it Wants but Doesn't Need MedivationRead the original story w/Photo

    Apr 29, 2016 | TheStreet.com

    ... of its growth potential from new drugs. Sanofi on Friday talked up its emerging immunology franchise including dermatitis treatment Dupilumap, which is in Phase Three trials, and rheumatoid arthritis treatment Sarlumab, also in Phase Three trials. ...

    Comment?

  9. What do a French bulldog and a 3-year-old girl have in common?Read the original story w/Photo

    Apr 14, 2016 | Philly.com

    What do a French bulldog and a 3-year-old girl with atopic dermatitis have in common? Is there a tie between sleep apnea in an American bulldog and a 40-year-old obese man? What can human heart disease tell us about the heart problems of giant apes? These topics were among those tackled at the recent Zoobiquity 6 conference at the University of Pennsylvania, where about 200 physicians and medical students joined veterinarians to examine and reinforce the idea that, in some ways, there is no dividing line between human and animal medicine. Or, as keynote speaker Stephanie Murphy, director of the Division of Comparative Medicine at the National Institutes of Health, put it: "A liver is a liver is a liver."

    Comment?

  10. A New Moisturizing Treatment For Highly Sensitive Skin Is Now Available From PHat 5.5 On AmazonRead the original story

    Apr 16, 2016 | Emailwire.com

    Clearwater, Florida -- Seborrheic Dermatitis Face Cream is one of the latest products launched by popular American based skin care company pHat5.5. Although marketed as a face cream, this moisturizer is suitable for total body care and formulated with ingredients that can ease the symptoms of dermatitis and other skin aliments. Currently retailing on amazon.com , this cream is now reduced by 40% in a limited time special.

    Comment?

  11. A New Moisturizing Treatment For Highly Sensitive Skin Is Now Available From PHat 5.5 On AmazonRead the original story

    Apr 3, 2016 | Emailwire.com

    Clearwater, Florida -- Seborrheic Dermatitis Face Cream is one of the latest products launched by popular American based skin care company pHat5.5. Although marketed as a face cream, this moisturizer is suitable for total body care and formulated with ingredients that can ease the symptoms of dermatitis and other skin aliments. Currently retailing on amazon.com , this cream is now reduced by 40% in a limited time special.

    Comment?

  12. Why Regeneron Pharmaceuticals, Tronox, and Office Depot Jumped TodayRead the original story w/Photo

    Apr 1, 2016 | The Motley Fool

    ... Regeneron Pharmaceuticals Regeneron Pharmaceuticals finished up 12% after the company reported that its proposed dermatitis treatment dupilumab had produced encouraging data in two phase 3 studies. Regeneron said that using the drug helped improve ...

    Comment?

  13. SmartPractice Launches Reflection Sapphire Sensitive Nitrile...Read the original story w/Photo

    Mar 25, 2016 | PRWeb

    ... irritating substances can be avoided or replaced.* According to Curt Hamman, MD, Medical Director of the Contact Dermatitis Institute: "Symptoms of dermatitis affect more than 20 percent of dental workers." Many of these workers mistakenly ...

    Comment?

  14. FDA accepts Anacor's NDA for topical dermatitis treatment, action date January 7Read the original story w/Photo

    Mar 22, 2016 | Seeking Alpha

    The FDA accepts for review Anacor Pharmaceuticals' New Drug Application seeking approval of crisaborole topical ointment, 2% for the treatment of mild-to-moderate atopic dermatitis in adults and children. The agency's action date is January 7, 2017.

    Comment?

  15. Chugai Pharma Announces Phase II Global Study Results Of Nemolizumab...Read the original story

    Mar 6, 2016 | BioSpace

    Chugai Pharmaceutical Co., Ltd. announced that the results of global phase II study of anti-IL-31 receptor A, humanized monoclonal antibody, nemolizumab , which is currently developed for atopic dermatitis, were released at the annual meeting of the American Academy of Dermatology currently held in Washington, D.C. The results were released at the Late-breaking Research Forums at 10:00 on Saturday, March 5 . "We are delighted that the efficacy and safety results in this study have demonstrated the possibility of CIM331 to provide a new treatment concept for patients around the world."

    Comment?

  16. Chugai Announces Phase II Global Study R ...Read the original story

    Mar 5, 2016 | The Financial Mirror

    Chugai Pharmaceutical Co., Ltd. announced that the results of global phase II study of anti-IL-31 receptor A, humanized monoclonal antibody, nemolizumab , which is currently developed for atopic dermatitis, were released at the annual meeting of the American Academy of Dermatology currently held in Washington, D.C. The results were released at the Late-breaking Research Forums at 10:00 on Saturday, March 5 . The global phase II study was conducted to evaluate the efficacy and safety of CIM331 in 264 patients with moderate to severe atopic dermatitis.

    Comment?

  17. Qurient garners spotlight from biotech i...Read the original story w/Photo

    Mar 2, 2016 | Korea Herald

    ... that the company will license out some 400 billion won worth of its new drug pipelines - one for treating atopic dermatitis and another for tuberculosis - and move into the black with sales of about 9.2 billion won this year. Qurient was spun off ...

    Comment?

  18. The Amazing Health and Beauty Benefits of Olive OilRead the original story w/Photo

    Feb 5, 2016 | Natural Holistic Health

    ... - the regular olive oil is not as effective. Emollients containing olive oil are useful in psoriasis , eczema and dermatitis treatment; they slow the loss of water through the skin layers. The thicker the cream or lotion, the more effective it is ...

    Comment?

  19. Wild Naturals Manuka Honey Moisturizer Effective For Treating Symptoms Of DermatitisRead the original story

    Jan 1, 2016 | Emailwire.com

    Clearwater, FL -- Wild Naturals , providers of all-natural and organic skin care and hair care products, announces that its Manuka Honey Moisturizer has been shown to relieve the symptoms associated with dermatitis. Dermatitis as the general term used to describe an inflammation of the skin which is also accompanied by an itchy rash.

    Comment?

  20. All-Natural Therapeutic Body Wash Shown To Be Effective For Treating Symptoms Of DermatitisRead the original story

    Nov 29, 2015 | Emailwire.com

    Clearwater, FL -- Wild Naturals , providers of natural and organic beauty products, announces that its Eczema & Psoriasis Body Wash has been shown to relieve the symptoms associated with dermatitis. Doctors and researchers at Mayoclinic.org define dermatitis as an inflammation of the skin that is accompanied by an itchy rash.

    Comment?